Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Total Liabilities data on file, last reported at $222.9 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $222.9 million, up 6.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $222.9 million (up 6.94% YoY), and the FY2025 annual result was $222.2 million, up 3.56% from the prior year.
• Total Liabilities held at $222.9 million in Q1 2026 per LMAT's latest filing, from $222.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $222.9 million in Q1 2026 and troughed at $34.7 million in Q1 2022.
• A 5-year average of $104.3 million and a median of $45.5 million in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities sank 50.37% in 2022, then jumped 393.5% in 2025.
• A 5-year view of Total Liabilities shows it stood at $42.3 million in 2022, then grew by 15.62% to $48.9 million in 2023, then soared by 338.9% to $214.5 million in 2024, then gained by 3.56% to $222.2 million in 2025, then increased by 0.33% to $222.9 million in 2026.
• Business Quant data shows LMAT's Total Liabilities at $222.9 million in Q1 2026, $222.2 million in Q4 2025, and $219.1 million in Q3 2025.